Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,480 INR | +0.58% |
|
-2.46% | +17.41% |
07:47am | Takeda gives Sun Pharma, Cipla rights to commercialize gastro drug in India | RE |
05:59am | Sun Pharma Signs Deal with Japan's Takeda to Commercialize Vonoprazan in India | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.41% | 42.2B | |
+21.27% | 21.24B | |
+21.73% | 15.89B | |
+25.29% | 14.91B | |
+58.39% | 13.1B | |
-0.05% | 6.79B | |
-14.83% | 6.24B | |
+21.38% | 6.08B | |
-8.87% | 5.73B | |
+25.45% | 4.56B |
- Stock Market
- Equities
- SUNPHARMA Stock
- News Sun Pharmaceutical Industries Ltd.
- Sector Update: Health Care Stocks Advance Tuesday Afternoon